- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05653440
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
Integrating Complementary Learning Principles in Aphasia Rehabilitation Via Adaptive Modeling (Sub-study 1: Balancing Effortful and Errorless Learning Via Adaptive Naming Deadlines)
Aphasia is a language disorder caused by stroke and other acquired brain injuries that affects over two million people in the United States and which interferes with life participation and quality of life. Anomia (i.e., word- finding difficulty) is a primary frustration for people with aphasia. Picture-based naming treatments for anomia are widely used in aphasia rehabilitation, but current treatment approaches do not address the long-term retention of naming abilities and do not focus on using these naming abilities in daily life. The current research aims to evaluate novel anomia treatment approaches to improve long-term retention and generalization to everyday life.
This study is one of two that are part of a larger grant. This record is for sub-study 1, which will adaptively balance effort and accuracy using speeded naming deadlines.
Study Overview
Status
Detailed Description
Study 1: Evaluate the benefits of balancing effortful and errorless learning via adaptive naming deadlines.
- Study design: The investigators will enroll 30 people with aphasia in a randomized within-subjects crossover design comparing trained words in three retrieval conditions. Stimuli will be balanced across conditions using an established item-response theory algorithm developed by Dr. Hula (consultant). Participants will receive 8 sessions of treatment per condition (2x/ week for 4 weeks), with probes administered at baseline and 1 week, 3 months, and 6 months post-treatment. Condition treatment order will be randomly assigned and counter- balanced across participants. In total, Sub-study 1 includes typically 3-4 (but up to 6) assessment sessions, 24 treatment sessions, and 24 baseline and follow-up probe assessment sessions per participant over an approximately 10-month period, but up to 18 months. Data collection will take place at the Language Rehabilitation and Cognition Laboratory (LRCL) at the University of Pittsburgh, in participants' homes, or in private rooms in public spaces (e.g. libraries, community centers).
- Participants: The investigators will recruit 30 male and female community-dwelling people with aphasia >6 months post- onset of aphasia due to left-hemisphere ischemic or hemorrhagic stroke. Aphasia diagnosis will be confirmed by Comprehensive Aphasia Test (CAT) performance and medical history. Investigators will exclude potential participants with a history of other acquired or progressive neurological disease, significant language comprehension impairments, unmanaged drug/alcohol dependence, and severe diagnosed mood or behavioral disorders that require specialized mental health interventions.
- Assessment Procedures: Participants will be tested on a comprehensive initial battery of standardized assessments characterizing their aphasia severity and overall language profile, naming and discourse abilities, semantic processing, verbal short-term and working memory at baseline. Patient-reported measures of treatment motivation and pre-post changes in communication effectiveness will also be measured in response to each treatment condition. These tests will ensure that our participants well-characterized from a behavioral perspective, and measures will be used in secondary analyses and model development exploring predictors of treatment response.
- Treatment description: Each training trial will consist of a fixation cross and picture presentation. A repetition cue (audio recording and written from of the target) will be provided to participants based on the deadlines described above. Participants will be instructed to name the picture and indicate when they have given their final answer via key press, with responses also timed and scored by clinician key press. In the errorless condition, they will be instructed to repeat the target, while in the other conditions they will be asked to try to name the picture independently before they hear the target. Once they have indicated that they have provided their final answer, they will receive accuracy feedback on the computer screen based on clinician scoring. To maximize the clinical relevance of this study, investigators will control total amount of treatment time (8 hours) between conditions, instead of controlling the total number of trials. This is because many more trials can be completed per hour in the errorless or balanced conditions compared to the effort-maximized condition, and investigators want study outcomes to practically inform clinicians on how best to spend limited treatment time.
Study Type
Enrollment (Estimated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Alyssa Kelly, M.A., CCC-SLP
- Phone Number: 412-648-3274
- Email: ank155@pitt.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15260
- Recruiting
- Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh
-
Contact:
- William Evans, PhD
- Phone Number: 412-383-6943
- Email: will.evans@pitt.edu
-
Principal Investigator:
- William Evans, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Existing diagnosis of chronic (>6 months) aphasia subsequent to left hemisphere ischemic or hemorrhagic stroke.
- Impaired performance on 2/8 sections of the Comprehensive Aphasia Test.
Exclusion Criteria:
- History of other acquired or progressive neurological disease.
- Significant language comprehension impairments
- Unmanaged drug / alcohol dependence.
- Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Effort-maximized, then accuracy-maximized, then effort-accuracy balanced
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
|
Experimental: Effort-maximized, then effort-accuracy balanced, then accuracy-maximized
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
|
Experimental: Accuracy-maximized, then effort-maximized, then effort-accuracy balanced
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
|
Experimental: Accuracy-maximized, then effort-accuracy balanced, then effort-maximized
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
|
Experimental: Effort-accuracy balanced, then effort-maximized, then accuracy maximized
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
|
Experimental: Effort-accuracy balanced, then accuracy-maximized, then effort-maximized
All participants will receive all three naming treatment conditions in a randomized order - this is one possible ordering of those conditions.
|
Naming treatment condition in which the target will be immediately provided for repetition at picture onset.
Naming treatment condition in which participants will have up to 10 seconds to respond before the target is provided for repetition.
Naming treatment condition in which naming deadlines will be determined based on the balanced effort-to-accuracy benefit ratio formalized above, calculated on clinician-provided accuracy and response time ratings.
Deadlines will be recalculated session-by-session to adjust to participant-specific treatment gains over time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in correct responses in Confrontation Naming of Treated Pictured Objects
Time Frame: Initial assessment (pre-treatment), 3 months post-treatment
|
Confrontation naming accuracy of pictures targeted in each training condition will serve as a primary outcome.
Individualized lists for each participant will be selected from a corpus of pictured objects.
Performance will be evaluated twice at each timepoint.
Change in performance from initial assessment to the 3-month follow-up timepoint on the treated items will serve as the primary outcome measure.
|
Initial assessment (pre-treatment), 3 months post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean scores on the Aphasia Communication Outcome Measure Short-Form
Time Frame: Initial assessment (pre-treatment), 1 week post-treatment.
|
The Aphasia Communication Outcome Measure (ACOM) is a measure of patient-reported "communication functioning," defined as the ability to effectively convey and receive personally relevant messages in natural environments.
Results are provided in T scores (sample mean of 50 with a standard deviations of 10), with higher scores indicating better communication functioning.
|
Initial assessment (pre-treatment), 1 week post-treatment.
|
|
Score on the Adapted Intrinsic Motivation Inventory for Aphasia
Time Frame: 1 week post-treatment
|
The adapted intrinsic motivation Inventory for aphasia is a brief instrument comprised of 7 subscales with a total of 45 items intended to characterize intrinsic motivation in people with aphasia.
Each item is scored on a scale of 1-7.
Higher total score is associated with higher intrinsic motivation.
|
1 week post-treatment
|
|
Change in core lexicon analysis on the Aphasia Bank Discourse Protocol
Time Frame: Initial assessment (pre-treatment), 3-months post-treatment
|
The Aphasia Bank Discourse Protocol is a brief, but thorough set of language tasks which will characterize participants' language at the discourse level.
The protocol requires participants to generate discourse samples within the contexts of free speech, a picture description, a story narrative, and procedural discourse.
Change in performance in core lexicon analysis on discourse samples from initial assessment to each post-treatment follow up timepoint will serve as a secondary outcome measure.
|
Initial assessment (pre-treatment), 3-months post-treatment
|
|
Change in correct responses in Confrontation Naming of Untreated Pictured Objects
Time Frame: Initial assessment (pre-treatment), 3 months post-treatment
|
Confrontation naming accuracy of pictured untreated items (matched for linguistic difficulty to treated items in the primary outcome) for each training condition will serve as a secondary outcome control condition.
|
Initial assessment (pre-treatment), 3 months post-treatment
|
|
Change in correct responses in Context Generalization of Treated and Untreated Pictured Objects
Time Frame: Initial assessment (pre-treatment), 3 months post-treatment
|
Production of trained words on the context generalization complex scene description task for each training condition and corresponding untreated items will serve as a secondary outcome.
Words from complex scenes and wordless picture books will be chosen for each participant.
These words will consist of a subset of those selected for confrontation naming.
Performance will be evaluated twice at each timepoint.
Change in performance from initial assessment to the 3-month follow-up timepoint on the treated and untreated items will serve as a secondary outcome measure.
|
Initial assessment (pre-treatment), 3 months post-treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: William Evans, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Neurobehavioral Manifestations
- Communication Disorders
- Language Disorders
- Speech Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Stroke
- Aphasia
Other Study ID Numbers
- STUDY21120130 (Study 1)
- 1R01DC019325-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The data sharing plan for this study includes the publication of discourse measures and other study data on Aphasia Bank (R01-DC008524), a large online repository of aphasia behavioral data that supports a great deal of productive aphasia corpora research. De-identified test scores, treatment, and probe data, and audio and/or video recordings of norming, probe, assessment, and treatment data will be shared to this repository for all study participants.
Investigators will also make our experimental task files, protocols, and de-identified study data available through Open Science Framework (https://osf.io/) to encourage the replication, collaboration, and expansion of our work by other research groups.
Last, investigators plan to publish a modeling and statistical package in open-access software, R, which will include functionality for calculating speed-accuracy tradeoff optimality using our multinomial ex-Gaussian response time model approach.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Accuracy-maximized condition
-
Federal University of São PauloCompletedCarpal Tunnel Syndrome | Compression Neuropathy, Carpal Tunnel | Median Neuropathy, Carpal TunnelBrazil
-
AstesNot yet recruiting
-
IRCCS San RaffaeleCompleted
-
Beijing Shijitan Hospital, Capital Medical UniversityRecruitingAcute Ischemic Stroke | Cerebral AutoregulationChina
-
IRCCS San RaffaeleCompleted
-
Hasselt UniversityTRACE labs Ziekenhuis Oost-Limburg (ZOL)Recruiting
-
LifeScanCompletedDiabetes MellitusUnited Kingdom
-
UMC UtrechtDutch Heart FoundationNot yet recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III
-
Cardenal Herrera UniversityCompletedChronic Low-back Pain (cLBP)Spain
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States